Gene Therapy Slows Huntington’s Disease by 75% in Clinical Trial
A new gene therapy called AMT-130 has successfully slowed the progression of Huntington’s disease by 75% in clinical trials, marking the first time any treatment has effectively slowed this devastating neurological condition.